Michaela Nathrath

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Neyssa Marina, Sigbjørn Smeland, Stefan Bielack et al. · The Lancet Oncology · 2016 · 511 citations · Full text

Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency

Michal Kováč, Claudia Blattmann, Sebastian Ribi et al. · Nature Communications · 2015 · 337 citations · Full text

Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study

Barbara C. Worst, Cornelis M. van Tilburg, Gnana Prakash Balasubramanian et al. · European Journal of Cancer · 2016 · 329 citations · Full text

Health Informatics, Cancer Literacy, Medicine +7

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

Vanya Icheva, Simone Kayser, Daniel Wolff et al. · Journal of Clinical Oncology · 2012 · 266 citations · Full text

The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets

Cornelis M. van Tilburg, Elke Pfaff, Kristian W. Pajtler et al. · Cancer Discovery · 2021 · 236 citations · Full text